Dry Eye — Point of Care Test of LTA Level in Tear Fluid, Measured With a POCT Test, in DE Patients Following IPL Treatment
Citation(s)
Arita R, Itoh K, Inoue K, Amano S Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008 May;115(5):911-5. doi: 10.1016/j.ophtha.2007.06.031.
Askeroglu U, Alleyne B, Guyuron B Pharmaceutical and herbal products that may contribute to dry eyes. Plast Reconstr Surg. 2013 Jan;131(1):159-167. doi: 10.1097/PRS.0b013e318272a00e.
Chen H, Chen H, Liang L, Zhong Y, Liang Y, Yu Y, Huang S, Lu X Evaluation of Tear Protein Markers in Dry Eye Disease with Different Lymphotoxin-Alpha Expression Levels. Am J Ophthalmol. 2020 Sep;217:198-211. doi: 10.1016/j.ajo.2020.03.013. Epub 2020 Mar 21.
Dell SJ, Gaster RN, Barbarino SC, Cunningham DN Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction. Clin Ophthalmol. 2017 May 2;11:817-827. doi: 10.2147/OPTH.S130706. eCollection 2017.
Evans V, Millar TJ, Eden JA, Willcox MD Menopause, hormone replacement therapy and tear function. Adv Exp Med Biol. 2002;506(Pt B):1029-33. doi: 10.1007/978-1-4615-0717-8_145. No abstract available.
Fraunfelder FT, Sciubba JJ, Mathers WD The role of medications in causing dry eye. J Ophthalmol. 2012;2012:285851. doi: 10.1155/2012/285851. Epub 2012 Aug 27. Erratum In: J Ophthalmol. 2019 Mar 4;2019:2989680.
Kang YS, Lee HS, Li Y, Choi W, Yoon KC Manifestation of meibomian gland dysfunction in patients with Sjogren's syndrome, non-Sjogren's dry eye, and non-dry eye controls. Int Ophthalmol. 2018 Jun;38(3):1161-1167. doi: 10.1007/s10792-017-0577-4. Epub 2017 May 31.
Li Q, Liu J, Liu C, Piao J, Yang W, An N, Zhu J Effects of intense pulsed light treatment on tear cytokines and clinical outcomes in meibomian gland dysfunction. PLoS One. 2021 Aug 26;16(8):e0256533. doi: 10.1371/journal.pone.0256533. eCollection 2021.
Liu J, Liu L, Zhou L, Chen L, Chen X, Xiong X, Deng Y The Effect of Intense Pulsed Light on the Skin Microbiota and Epidermal Barrier in Patients with Mild to Moderate Acne Vulgaris. Lasers Surg Med. 2021 Dec;53(10):1348-1355. doi: 10.1002/lsm.23426. Epub 2021 Jul 5.
Liu R, Rong B, Tu P, Tang Y, Song W, Toyos R, Toyos M, Yan X Analysis of Cytokine Levels in Tears and Clinical Correlations After Intense Pulsed Light Treating Meibomian Gland Dysfunction. Am J Ophthalmol. 2017 Nov;183:81-90. doi: 10.1016/j.ajo.2017.08.021. Epub 2017 Sep 6.
Ma J, Li C, Zhao Y, Shen Z, Hu B, Peng R, Hong J Ophthalmic manifestations are associated with reduced tear lymphotoxin-alpha levels in chronic ocular graft-versus-host disease. BMC Ophthalmol. 2022 Jan 10;22(1):18. doi: 10.1186/s12886-022-02251-y.
Rong B, Tang Y, Liu R, Tu P, Qiao J, Song W, Yan X Long-Term Effects of Intense Pulsed Light Combined with Meibomian Gland Expression in the Treatment of Meibomian Gland Dysfunction. Photomed Laser Surg. 2018 Oct;36(10):562-567. doi: 10.1089/pho.2018.4499. Epub 2018 Sep 22.
Taudorf EH, Olsen J, Lindso Andersen P, Bouazzi D, Jemec GBE Dynamic Optical Coherence Tomography Imaging of Telangiectasia Prior to Intense Pulsed Light Treatment-An Opportunity to Target Treatment? Lasers Surg Med. 2021 Feb;53(2):212-218. doi: 10.1002/lsm.23280. Epub 2020 Jun 12.
Tavassoli S, Wong N, Chan E Ocular manifestations of rosacea: A clinical review. Clin Exp Ophthalmol. 2021 Mar;49(2):104-117. doi: 10.1111/ceo.13900. Epub 2021 Feb 3.
Thode AR, Latkany RA Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD). Drugs. 2015 Jul;75(11):1177-85. doi: 10.1007/s40265-015-0432-8.
Uchino Y, Uchino M, Dogru M, Ward S, Yokoi N, Tsubota K Changes in dry eye diagnostic status following implementation of revised Japanese dry eye diagnostic criteria. Jpn J Ophthalmol. 2012 Jan;56(1):8-13. doi: 10.1007/s10384-011-0099-y. Epub 2011 Nov 15.
Viso E, Rodriguez-Ares MT, Abelenda D, Oubina B, Gude F Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci. 2012 May 4;53(6):2601-6. doi: 10.1167/iovs.11-9228.
Wang B, Wu Y, Luo YJ, Xu XG, Xu TH, Chen JZ, Gao XH, Chen HD, Li YH Combination of intense pulsed light and fractional CO(2) laser treatments for patients with acne with inflammatory and scarring lesions. Clin Exp Dermatol. 2013 Jun;38(4):344-51. doi: 10.1111/ced.12010. Epub 2013 Apr 3.
Yokoi N, Takehisa Y, Kinoshita S Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye. Am J Ophthalmol. 1996 Dec;122(6):818-24. doi: 10.1016/s0002-9394(14)70378-2.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.